Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Octreotide × CNS × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Endocrine 2 Thoracic 1 NET 1 CNS 1 Breast 1

Conditions

Interventions

Radiotherapy 53 Temozolomide 35 Vincristine 28 Cyclophosphamide 27 Etoposide 23 Carboplatin 21 Filgrastim 20 Cisplatin 19 Granulocyte Colony-Stimulating Factor 16 Lomustine 13 Topotecan 11 Doxorubicin 11 Chemotherapy, Adjuvant 11 Radiation 10 Peripheral Blood Stem Cell Transplantation 10 Isotretinoin 10 Radiotherapy, Conformal 9 Magnetic Resonance Spectroscopy 9 Carmustine 9 sargramostim 8 Specimen Handling 8 Radiotherapy, Intensity-Modulated 8 Radiosurgery 8 Platinum 8 Irinotecan 8 1,2-diaminocyclohexaneplatinum II citrate 8 etoposide phosphate 7 Thiotepa 7 Melphalan 7 Immunohistochemistry 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡